Facia Men

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

nicotinamide, Quantity: 5 mg; zinc amino acid chelate, Quantity: 10 mg (Equivalent: zinc, Qty 2 mg); calcium pantothenate, Quantity: 20 mg; d-alpha-tocopheryl acid succinate, Quantity: 4.13 mg (Equivalent: d-alpha-tocopherol, Qty 5 IU); Biotin, Quantity: 2.5 mg; retinol palmitate, Quantity: 0.2807 mg; cysteine hydrochloride, Quantity: 45.6 mg (Equivalent: cysteine, Qty 35 mg); Serenoa repens, Quantity: 240 mg (Equivalent: Serenoa repens, Qty 960 mg); Cucurbita pepo, Quantity: 10 mg (Equivalent: Cucurbita pepo, Qty 200 mg); riboflavin, Quantity: 2 mg

Verfügbar ab:

Contract Manufacturing & Packaging Services Pty Ltd

INN (Internationale Bezeichnung):

Biotin,cysteine hydrochloride,Calcium pantothenate,Cucurbita pepo,d-alpha-Tocopheryl acid succinate,Nicotinamide,retinol palmita

Darreichungsform:

Capsule, hard

Zusammensetzung:

Excipient Ingredients: magnesium stearate; titanium dioxide; calcium hydrogen phosphate dihydrate; Collagen; colloidal anhydrous silica; Gelatin; brilliant blue FCF; quinoline yellow; sodium lauryl sulfate; carmoisine; purified water; maize starch; dl-alpha-tocopherol; sucrose

Verabreichungsweg:

Oral

Anwendungsgebiete:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support hair growth ; Maintain/support hair health ; Maintain/support preconception health ; Maintain/support reproductive system health ; Traditionally used in Western herbal medicine to Help maintain/support healthy prostate function ; Traditionally used in Western herbal medicine to Maintain/support prostate health ; Maintain/support sperm health ; Maintain/support sperm production ; Maintain/support skin health ; Maintain/support skin integrity/structure ; Maintain/support skin regeneration ; Maintain/support wound healing

Produktbesonderheiten:

Visual Identification: ; Container Type: Multiple containers; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2016-12-21